Amphotericin B
Amphotericin B is a pharmaceutical drug with 37 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
9
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.1%
27 of 31 finished
12.9%
4 ended early
1
trials recruiting
37
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
Clinical Trials (37)
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
Dexamethasone in Cryptococcal Meningitis
Treatment With Tamoxifen in Cryptococcal Meningitis
AmB Dose for Cryptococcal Meningitis
Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
Antimicrobial PK in Infants With Suspected or Confirmed Infection
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 37